What is Wegovy and how it works for weight loss
Wegovy (semaglutide 2.4 mg) is an FDA-approved prescription medicine for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition. It mimics the hormone GLP-1 to reduce hunger, increase fullness, and slow gastric emptying, helping people eat fewer calories without constant willpower. When combined with lifestyle changes like a reduced-calorie diet and regular activity, Wegovy can lead to meaningful and sustained weight loss. This guide explains how it works, who may benefit, what to expect, and practical steps to use it safely and effectively.
Eligibility and who may benefit most
Wegovy is indicated for adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or dyslipidemia. A healthcare professional will consider your full medical history, current medications, and metabolic health before prescribing. It is not a first-line diet pill but rather a tool for people who have not achieved sufficient results with lifestyle changes alone. If you are pregnant, breastfeeding, or have certain medical conditions, Wegovy may not be suitable. A qualified clinician can assess your eligibility and discuss realistic expectations.
Dosing schedule and titration process
Starting and increasing the dose over time
Wegovy is started at a low dose to reduce the chance of side effects and gradually increased by your prescriber according to a set schedule. The needle is injected once weekly under the skin, usually in the abdomen, thigh, or upper arm. Dose adjustments are typically spaced by weeks and are guided by your response and tolerability. Following the titration schedule helps your body adapt and supports consistent use. Always follow your clinician’s instructions and report persistent or severe side effects rather than changing doses on your own.
| Dose | Typical Use Context | Source Type |
|---|---|---|
| 0.25 mg weekly | Initiation and early titration | Prescribing Information |
| 0.5 mg weekly | First therapeutic titration step | Prescribing Information |
| 1.0 mg weekly | Therapeutic maintenance for many adults | Prescribing Information |
| 1.7 mg weekly | Maximum approved dose for some adults | Prescribing Information |
Effectiveness and what to expect over time
Clinical trials show that adults using Wegovy with lifestyle changes can lose a meaningful percentage of their body weight. On average, participants in controlled studies achieved around 12–15% total weight loss over 68 weeks, though results vary by baseline weight, adherence, and comorbidities. Weight loss usually begins within the first few weeks, with more noticeable changes as the dose is increased and lifestyle habits improve. Gains in blood pressure, blood sugar, and cardiometabolic markers often accompany weight loss. Individual outcomes depend on consistency with diet, activity, follow-up care, and how your body responds.
Possible side effects and how to manage them
The most common side effects of Wegovy are gastrointestinal and may include nausea, vomiting, diarrhea, constipation, and stomach pain. These symptoms often decrease over time as your body adjusts and when doses are increased slowly. To reduce nausea, avoid large or very greasy meals, eat smaller portions, and stay hydrated. Serious risks such as pancreatitis, gallbladder problems, and changes in heart rate have been reported in some people using GLP-1 receptor agonists. If you experience severe abdominal pain, persistent vomiting, jaundice, or symptoms of an allergic reaction, seek medical care right away. Regular follow-ups help manage side effects and adjust treatment safely.
Cost, access, and insurance considerations
Wegovy can be costly without insurance, and many plans require prior authorization or place it on specialty tiers. Costs vary by pharmacy, location, and whether you use a manufacturer co-pay program or patient assistance options. Some clinics offer compounded semaglutide at a lower price, but those versions are not FDA-approved and may have different safety and quality considerations. Talk to your prescriber and insurer about expected out-of-pocket costs, step therapy requirements, and whether a savings program could help. Comparing prices across pharmacies and staying informed about formulary changes can improve access and reduce surprise bills.